MGAT5 and non-small cell lung carcinoma: A study reported that the expression level of beta 1,6-N-acetylglucosaminyl transferase (GnT-V) was decreased in 50% of patients with NSCLC, resulting in a decrease in the βl,6 GlcNAc branch of the N-glycan structure, which was associated with a poor prognosis of NSCLC [72].